Accelerator Mass Spectrometry in Biomedical Dosimetry: Relationship Between Low-Level Exposure and Covalent Binding of Heterocyclic Amine Carcinogens to DNA

Accelerator mass spectrometry (AMS) is used to determine the amount of carcinogen covalently bound to mouse liver DNA (DNA adduct) following very low-level exposure to a14C-labeled carcinogen. AMS is a highly sensitive method for counting long-lived but rare cosmogenic isotopes. While AMS is a tool...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 87; no. 14; pp. 5288 - 5292
Main Authors Turteltaub, K. W., Felton, J. S., Gledhill, B. L., Vogel, J. S., Southon, J. R., Caffee, M. W., Finkel, R. C., Nelson, D. E., Proctor, I. D., Davis, J. C.
Format Journal Article
LanguageEnglish
Published Washington, DC National Academy of Sciences of the United States of America 01.07.1990
National Acad Sciences
Subjects
Online AccessGet full text
ISSN0027-8424
1091-6490
DOI10.1073/pnas.87.14.5288

Cover

Loading…
Abstract Accelerator mass spectrometry (AMS) is used to determine the amount of carcinogen covalently bound to mouse liver DNA (DNA adduct) following very low-level exposure to a14C-labeled carcinogen. AMS is a highly sensitive method for counting long-lived but rare cosmogenic isotopes. While AMS is a tool of importance in the earth sciences, it has not been applied in biomedical research. The ability of AMS to assay rare isotope concentrations (10Be,14C,26Al,41Ca, and129I) in microgram amounts suggests that extension to the biomedical sciences is a natural and potentially powerful application of the technology. In this study, the relationship between exposure to low levels of 2-amino-3,8-dimethyl[2-14C]imidazo[4,5-f]quinoxaline and formation of DNA adducts is examined to establish the dynamic range of the technique and the potential sensitivity for biological measurements, as well as to evaluate the relationship between DNA adducts and low-dose carcinogen exposure. Instrument reproducibility in this study is 2%; sensitivity is 1 adduct per 1011nucleotides. Formation of adducts is linearly dependent on dose down to an exposure of 500 ng per kg of body weight. With the present measurements, we demonstrate at least 1 order of magnitude improvement over the best adduct detection sensitivity reported to date and 3-5 orders of magnitude improvement over other methods used for adduct measurement. An additional improvement of 2 orders of magnitude in sensitivity is suggested by preliminary experiments to develop bacterial hosts depleted in radiocarbon. Expanded applications involving human subjects, including clinical applications, are now expected because of the great detection sensitivity and small sample size requirements of AMS.
AbstractList Accelerator mass spectrometry (AMS) is used to determine the amount of carcinogen covalently bound to mouse liver DNA (DNA adduct) following very low-level exposure to a {sup 14}C-labeled carcinogen. AMS is a highly sensitive method for counting long-lived but rare cosmogenic isotopes. While AMS is a tool of importance in the earth sciences, it has not been applied in biomedical research. The ability of AMS to assay rare isotope concentrations ({sup 10}Be, {sup 14}C, {sup 26}Al, {sup 41}Ca, and {sup 129}I) in microgram amounts suggests that extension to the biomedical sciences is a natural and potentially powerful application of the technology. In this study, the relationship between exposure to low levels of 2-amino-3,8-dimethyl(2-{sup 14}C)imidazo(4,5-f)quinoxaline and formation of DNA adducts is examined to establish the dynamic range of the technique and the potential sensitivity for biological measurements, as well as to evaluate the relationship between DNA adducts and low-dose carcinogen exposure. Formation of adducts is linearly dependent on dose down to an exposure of 500 ng per kg of body weight. With the present measurements, the authors demonstrate at least 1 order of magnitude improvement over the best adduct detection sensitivity reported to data and 3-5 orders of magnitude improvement over other methods used for adduct measurement. Expanded applications involving human subjects, including clinical applications, are now expected because of the great detection sensitivity and small sample size requirements of AMS.
Accelerator mass spectrometry (AMS) is used to determine the amount of carcinogen covalently bound to mouse liver DNA (DNA adduct) following very low-level exposure to a 14C-labeled carcinogen. AMS is a highly sensitive method for counting long-lived but rare cosmogenic isotopes. While AMS is a tool of importance in the earth sciences, it has not been applied in biomedical research. The ability of AMS to assay rare isotope concentrations (10Be, 14C, 26Al, 41Ca, and 129I) in microgram amounts suggests that extension to the biomedical sciences is a natural and potentially powerful application of the technology. In this study, the relationship between exposure to low levels of 2-amino-3,8-dimethyl[2-14C]imidazo[4,5-f]quinoxaline and formation of DNA adducts is examined to establish the dynamic range of the technique and the potential sensitivity for biological measurements, as well as to evaluate the relationship between DNA adducts and low-dose carcinogen exposure. Instrument reproducibility in this study is 2%; sensitivity is 1 adduct per 10(11) nucleotides. Formation of adducts is linearly dependent on dose down to an exposure of 500 ng per kg of body weight. With the present measurements, we demonstrate at least 1 order of magnitude improvement over the best adduct detection sensitivity reported to date and 3-5 orders of magnitude improvement over other methods used for adduct measurement. An additional improvement of 2 orders of magnitude in sensitivity is suggested by preliminary experiments to develop bacterial hosts depleted in radiocarbon. Expanded applications involving human subjects, including clinical applications, are now expected because of the great detection sensitivity and small sample size requirements of AMS.
Accelerator mass spectrometry (AMS) is used to determine the amount of carcinogen covalently bound to mouse liver DNA (DNA adduct) following very low-level exposure to a14C-labeled carcinogen. AMS is a highly sensitive method for counting long-lived but rare cosmogenic isotopes. While AMS is a tool of importance in the earth sciences, it has not been applied in biomedical research. The ability of AMS to assay rare isotope concentrations (10Be,14C,26Al,41Ca, and129I) in microgram amounts suggests that extension to the biomedical sciences is a natural and potentially powerful application of the technology. In this study, the relationship between exposure to low levels of 2-amino-3,8-dimethyl[2-14C]imidazo[4,5-f]quinoxaline and formation of DNA adducts is examined to establish the dynamic range of the technique and the potential sensitivity for biological measurements, as well as to evaluate the relationship between DNA adducts and low-dose carcinogen exposure. Instrument reproducibility in this study is 2%; sensitivity is 1 adduct per 1011nucleotides. Formation of adducts is linearly dependent on dose down to an exposure of 500 ng per kg of body weight. With the present measurements, we demonstrate at least 1 order of magnitude improvement over the best adduct detection sensitivity reported to date and 3-5 orders of magnitude improvement over other methods used for adduct measurement. An additional improvement of 2 orders of magnitude in sensitivity is suggested by preliminary experiments to develop bacterial hosts depleted in radiocarbon. Expanded applications involving human subjects, including clinical applications, are now expected because of the great detection sensitivity and small sample size requirements of AMS.
Accelerator mass spectrometry (AMS) is used to determine the amount of carcinogen covalently bound to mouse liver DNA (DNA adduct) following very low-level exposure to a 14C-labeled carcinogen. AMS is a highly sensitive method for counting long-lived but rare cosmogenic isotopes. While AMS is a tool of importance in the earth sciences, it has not been applied in biomedical research. The ability of AMS to assay rare isotope concentrations (10Be, 14C, 26Al, 41Ca, and 129I) in microgram amounts suggests that extension to the biomedical sciences is a natural and potentially powerful application of the technology. In this study, the relationship between exposure to low levels of 2-amino-3,8-dimethyl[2-14C]imidazo[4,5-f]quinoxaline and formation of DNA adducts is examined to establish the dynamic range of the technique and the potential sensitivity for biological measurements, as well as to evaluate the relationship between DNA adducts and low-dose carcinogen exposure. Instrument reproducibility in this study is 2%; sensitivity is 1 adduct per 10(11) nucleotides. Formation of adducts is linearly dependent on dose down to an exposure of 500 ng per kg of body weight. With the present measurements, we demonstrate at least 1 order of magnitude improvement over the best adduct detection sensitivity reported to date and 3-5 orders of magnitude improvement over other methods used for adduct measurement. An additional improvement of 2 orders of magnitude in sensitivity is suggested by preliminary experiments to develop bacterial hosts depleted in radiocarbon. Expanded applications involving human subjects, including clinical applications, are now expected because of the great detection sensitivity and small sample size requirements of AMS.Accelerator mass spectrometry (AMS) is used to determine the amount of carcinogen covalently bound to mouse liver DNA (DNA adduct) following very low-level exposure to a 14C-labeled carcinogen. AMS is a highly sensitive method for counting long-lived but rare cosmogenic isotopes. While AMS is a tool of importance in the earth sciences, it has not been applied in biomedical research. The ability of AMS to assay rare isotope concentrations (10Be, 14C, 26Al, 41Ca, and 129I) in microgram amounts suggests that extension to the biomedical sciences is a natural and potentially powerful application of the technology. In this study, the relationship between exposure to low levels of 2-amino-3,8-dimethyl[2-14C]imidazo[4,5-f]quinoxaline and formation of DNA adducts is examined to establish the dynamic range of the technique and the potential sensitivity for biological measurements, as well as to evaluate the relationship between DNA adducts and low-dose carcinogen exposure. Instrument reproducibility in this study is 2%; sensitivity is 1 adduct per 10(11) nucleotides. Formation of adducts is linearly dependent on dose down to an exposure of 500 ng per kg of body weight. With the present measurements, we demonstrate at least 1 order of magnitude improvement over the best adduct detection sensitivity reported to date and 3-5 orders of magnitude improvement over other methods used for adduct measurement. An additional improvement of 2 orders of magnitude in sensitivity is suggested by preliminary experiments to develop bacterial hosts depleted in radiocarbon. Expanded applications involving human subjects, including clinical applications, are now expected because of the great detection sensitivity and small sample size requirements of AMS.
Accelerator mass spectrometry (AMS) is used to determine the amount of carcinogen covalently bound to mouse liver DNA (DNA adduct) following very low-level exposure to a super(14)C-labeled carcinogen. AMS is a highly sensitive method for counting long-lived but rare cosmogenic isotopes. While AMS is a tool of importance in the earth sciences, it has not been applied in biomedical research. The ability of AMS to assay rare isotope concentrations ( super(10)Be, super(14)C, super(26)Al, super(41)Ca, and super(129)I) in microgram amounts suggests that extension to the biomedical sciences is a natural and potentially powerful application of the technology. In this study, the relationship between exposure to low levels of 2-amino-3,8-dimethyl(2- super(14)C)imidazo(4,5-f)quinoxaline and formation of DNA adducts is examined to establish the dynamic range of the technique and the potential sensitivity for biological measurements, as well as to evaluate the relationship between DNA adduct and low-dose carcinogen exposure.
Author Proctor, I. D.
Gledhill, B. L.
Felton, J. S.
Caffee, M. W.
Nelson, D. E.
Finkel, R. C.
Vogel, J. S.
Southon, J. R.
Turteltaub, K. W.
Davis, J. C.
AuthorAffiliation Biomedical Sciences Division, University of California, Livermore 94550
AuthorAffiliation_xml – name: Biomedical Sciences Division, University of California, Livermore 94550
Author_xml – sequence: 1
  givenname: K. W.
  surname: Turteltaub
  fullname: Turteltaub, K. W.
– sequence: 2
  givenname: J. S.
  surname: Felton
  fullname: Felton, J. S.
– sequence: 3
  givenname: B. L.
  surname: Gledhill
  fullname: Gledhill, B. L.
– sequence: 4
  givenname: J. S.
  surname: Vogel
  fullname: Vogel, J. S.
– sequence: 5
  givenname: J. R.
  surname: Southon
  fullname: Southon, J. R.
– sequence: 6
  givenname: M. W.
  surname: Caffee
  fullname: Caffee, M. W.
– sequence: 7
  givenname: R. C.
  surname: Finkel
  fullname: Finkel, R. C.
– sequence: 8
  givenname: D. E.
  surname: Nelson
  fullname: Nelson, D. E.
– sequence: 9
  givenname: I. D.
  surname: Proctor
  fullname: Proctor, I. D.
– sequence: 10
  givenname: J. C.
  surname: Davis
  fullname: Davis, J. C.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19545497$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/2371271$$D View this record in MEDLINE/PubMed
https://www.osti.gov/biblio/6151460$$D View this record in Osti.gov
BookMark eNqFkstuEzEUhkeoqKSFNRtAFhKwmtSesccexCZNC0UKIHFZWx7nTOJqYk9tJ23ehYfFaULUIgErH_l8_7kfZQfWWciypwQPCeblSW9VGAo-JHTICiEeZAOCa5JXtMYH2QDjgueCFvRRdhTCJca4ZgIfZodFyUnBySD7OdIaOvAqOo8-qRDQtx509G4B0a-RsejUJHtqtOrQmQvm9v8t-gqdisbZMDc9OoV4DWDRxF3nE1hBh85veheWHpCyUzR2K9WBjSmUnRo7Q65FFxDBO73WndFotDAW0Fh5baybgQ0oOnT2efQ4e9iqLsCT3Xuc_Xh__n18kU--fPg4Hk1yzTiLObQAFJpKVbhoKJkqghUuWyymDauJAtbUlGJaNpS1tSYgqnpKkwVYNS0nujzO3m3j9ssm9apTrV51svdmofxaOmXkfY81czlzK8loiUWSv9zKXYhGBm0i6Ll21qZByoowQiucoNe7HN5dLSFEuTAhjb5TFtwySF4LLjjl_wUJEyUuqzKBz-9WvS93t9vkf7Xzq5C213pltQl7jNSMMlpvErItp70LwUMrUwe3y029mk4SLDenJjenJgWXhMrNqSXdyR-6fei_Kl7sKto4ftP3gDf_BGS77LoINzGRz7bkZUiXe6d3xjDH5S-dqfvE
CODEN PNASA6
CitedBy_id crossref_primary_10_1016_S0027_5107_97_00049_3
crossref_primary_10_14494_jnrs2000_2_R9
crossref_primary_10_1002_tox_20295
crossref_primary_10_1016_j_taap_2005_04_022
crossref_primary_10_1002_jcph_569
crossref_primary_10_1039_c3an00077j
crossref_primary_10_1111_j_1600_0773_1992_tb00460_x
crossref_primary_10_1073_pnas_071047998
crossref_primary_10_1002_mnfr_200400076
crossref_primary_10_3109_10408449409021608
crossref_primary_10_1006_taap_1999_8722
crossref_primary_10_1016_0165_9936_92_87076_V
crossref_primary_10_15407_scin6_01_017
crossref_primary_10_1093_toxsci_kfn176
crossref_primary_10_1093_toxsci_kfp232
crossref_primary_10_1093_toxsci_kfj016
crossref_primary_10_1177_074823370001600312
crossref_primary_10_4155_bio_2019_0119
crossref_primary_10_1103_RevModPhys_95_035006
crossref_primary_10_1079_NRR200129
crossref_primary_10_1016_j_jpba_2021_114152
crossref_primary_10_1016_j_yrtph_2015_06_015
crossref_primary_10_1016_S0378_4274_98_00344_0
crossref_primary_10_1016_S0731_7085_00_00397_6
crossref_primary_10_1016_j_yrtph_2004_01_003
crossref_primary_10_1017_S0033822200053273
crossref_primary_10_1021_tx2004536
crossref_primary_10_1177_01926233211064180
crossref_primary_10_1111_j_1753_4887_2004_tb00008_x
crossref_primary_10_1081_DMR_120005665
crossref_primary_10_1016_S0955_2863_97_00080_6
crossref_primary_10_1177_026119291804600603
crossref_primary_10_1255_ejms_1078
crossref_primary_10_1021_acs_analchem_6b02054
crossref_primary_10_1124_dmd_104_000422
crossref_primary_10_1016_j_nimb_2015_02_008
crossref_primary_10_1021_acs_chemrestox_5b00495
crossref_primary_10_1002_mas_20059
crossref_primary_10_1021_tx200135s
crossref_primary_10_1021_tx700125p
crossref_primary_10_1016_S0278_6915_98_00003_9
crossref_primary_10_1007_s002040050050
crossref_primary_10_1007_s00228_013_1528_2
crossref_primary_10_1128_AAC_03300_14
crossref_primary_10_1016_j_fct_2016_09_029
crossref_primary_10_1021_acs_analchem_4c04874
crossref_primary_10_1016_S0009_2797_03_00022_X
crossref_primary_10_1017_S0033822200058021
crossref_primary_10_1021_bi901059k
crossref_primary_10_1111_cts_12390
crossref_primary_10_1016_j_ijms_2013_05_023
crossref_primary_10_2144_05386SU04
crossref_primary_10_4155_bio_11_276
crossref_primary_10_1016_j_nimb_2012_08_054
crossref_primary_10_1016_j_nimb_2004_04_138
crossref_primary_10_1002_jms_1190301002
crossref_primary_10_1017_RDC_2024_47
crossref_primary_10_1038_s41467_021_26642_9
crossref_primary_10_1080_10506890009411512
crossref_primary_10_1517_14740338_1_3_253
crossref_primary_10_1016_j_fct_2007_08_027
crossref_primary_10_1016_S0304_3835_06_80035_2
crossref_primary_10_1016_j_nimb_2015_04_047
crossref_primary_10_4155_bio_09_188
crossref_primary_10_1016_S0009_2797_97_00061_6
crossref_primary_10_4155_bio_12_242
crossref_primary_10_1016_j_nimb_2016_10_038
crossref_primary_10_1002_mas_1280110602
crossref_primary_10_1016_j_ijms_2018_08_003
crossref_primary_10_1016_0168_1176_92_85077_D
crossref_primary_10_1038_nrd1037
crossref_primary_10_3390_foods11182828
crossref_primary_10_1016_j_nimb_2007_01_215
crossref_primary_10_1016_j_addr_2010_10_009
crossref_primary_10_1080_17576180_2025_2460391
crossref_primary_10_1016_j_mrgentox_2010_08_021
crossref_primary_10_4155_bio_11_285
crossref_primary_10_1021_ac971383v
crossref_primary_10_1080_026520300283360
crossref_primary_10_1016_S0168_583X_00_00230_5
crossref_primary_10_1016_j_mrgentox_2009_06_001
crossref_primary_10_1016_j_jchromb_2003_10_053
crossref_primary_10_1002_jcb_240531019
crossref_primary_10_1021_nl302412f
crossref_primary_10_1021_acs_accounts_9b00054
crossref_primary_10_1177_074823379300900406
crossref_primary_10_1006_abio_1998_2891
crossref_primary_10_1002__SICI_1097_0215_19990209_80_4_539__AID_IJC10_3_0_CO_2_C
crossref_primary_10_1021_jf100113c
crossref_primary_10_1007_BF02900404
crossref_primary_10_1073_pnas_040575997
crossref_primary_10_1016_S0300_483X_02_00250_0
crossref_primary_10_1006_taap_1997_8248
crossref_primary_10_1111_j_1349_7006_1993_tb02058_x
crossref_primary_10_1016_j_tips_2004_06_009
crossref_primary_10_1177_0091270005280051
crossref_primary_10_1158_0008_5472_CAN_06_1573
crossref_primary_10_1293_tox_14_213
crossref_primary_10_4155_fso_15_74
crossref_primary_10_1016_S0304_3835_99_00116_0
crossref_primary_10_1007_s00216_007_1306_z
crossref_primary_10_1002__SICI_1097_0231_19990228_13_4_285__AID_RCM469_3_0_CO_2_R
crossref_primary_10_1002__SICI_1098_2280_2000_35_1_57__AID_EM8_3_0_CO_2_7
crossref_primary_10_1002_mnfr_201200226
crossref_primary_10_1080_17425247_2016_1227786
crossref_primary_10_1016_S0890_6238_99_00011_8
crossref_primary_10_4155_bio_10_14
crossref_primary_10_1002_jps_21160
crossref_primary_10_1006_bbrc_2000_4161
crossref_primary_10_1016_S0168_583X_00_00235_4
crossref_primary_10_1016_S1383_5742_01_00059_X
crossref_primary_10_1021_ja5100542
crossref_primary_10_1093_carcin_20_3_353
crossref_primary_10_4155_bio_12_297
crossref_primary_10_1186_s41021_021_00200_7
crossref_primary_10_1021_ac103038s
crossref_primary_10_1002_rcm_5149
crossref_primary_10_1017_S0033822200063529
crossref_primary_10_1002_ijc_25814
crossref_primary_10_1373_clinchem_2005_049650
crossref_primary_10_3109_10408444_2013_835787
ContentType Journal Article
Copyright 1991 INIST-CNRS
Copyright_xml – notice: 1991 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7X8
OTOTI
5PM
DOI 10.1073/pnas.87.14.5288
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nucleic Acids Abstracts
MEDLINE - Academic
OSTI.GOV
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList



CrossRef
MEDLINE
MEDLINE - Academic
Nucleic Acids Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
EISSN 1091-6490
EndPage 5292
ExternalDocumentID PMC54308
6151460
2371271
19545497
10_1073_pnas_87_14_5288
87_14_5288
2355070
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, U.S. Gov't, P.H.S
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NIEHS NIH HHS
  grantid: 222Y-01-ES-70158
– fundername: NCI NIH HHS
  grantid: CA40811
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
123
29P
2AX
2FS
2WC
3O-
4.4
53G
5RE
5VS
85S
AACGO
AAFWJ
AANCE
ABBHK
ABOCM
ABPLY
ABPPZ
ABTLG
ABXSQ
ABZEH
ACGOD
ACHIC
ACIWK
ACNCT
ACPRK
ADQXQ
ADULT
ADXHL
AENEX
AEUPB
AEXZC
AFFNX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AQVQM
AS~
CS3
D0L
DCCCD
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HGD
HH5
HQ3
HTVGU
HYE
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
KQ8
L7B
LU7
MVM
N9A
NEJ
N~3
O9-
OK1
P-O
PNE
PQQKQ
R.V
RHI
RNA
RNS
RPM
RXW
SA0
SJN
TN5
UKR
VOH
W8F
WH7
WHG
WOQ
WOW
X7M
XSW
Y6R
YKV
YSK
ZCA
ZCG
~02
~KM
-
02
08R
0R
1AW
55
AAPBV
ABFLS
ABPTK
ADACO
ADZLD
AFDAS
AJYGW
AS
ASUFR
DNJUQ
DOOOF
DWIUU
DZ
F20
GJ
JSODD
KM
OHM
PQEST
RHF
VQA
X
XFK
XHC
ZA5
692
6TJ
79B
AAYJJ
AAYXX
ACKIV
AFHIN
AFQQW
BKOMP
CITATION
NHB
TAE
YBH
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
YIF
YIN
7TM
7X8
OTOTI
5PM
ID FETCH-LOGICAL-c575t-efee4eb6a602b41da10a03f08db591ae5b944043b45f9c1e869d4f9ce0abf71c3
ISSN 0027-8424
IngestDate Thu Aug 21 18:31:00 EDT 2025
Thu May 18 18:17:18 EDT 2023
Fri Jul 11 00:05:10 EDT 2025
Fri Jul 11 10:57:35 EDT 2025
Wed Feb 19 02:35:19 EST 2025
Mon Jul 21 09:15:34 EDT 2025
Thu Apr 24 23:02:02 EDT 2025
Tue Jul 01 01:22:04 EDT 2025
Wed Nov 11 00:29:26 EST 2020
Thu May 30 08:53:08 EDT 2019
Thu May 29 08:43:02 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 14
Keywords Quinoxaline derivatives
Radiolabelling
Liver
Rodentia
Cytotoxicity
Carcinogen
Vertebrata
Mammalia
Methylosinus trichosporium
Mouse
DNA
Molecular association
Covalent bond
Bacteria
Mass spectrometry
Molecular adduct
Physicochemical properties
Quantitative analysis
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c575t-efee4eb6a602b41da10a03f08db591ae5b944043b45f9c1e869d4f9ce0abf71c3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 2371271
PQID 15830363
PQPubID 23462
PageCount 5
ParticipantIDs crossref_citationtrail_10_1073_pnas_87_14_5288
pnas_primary_87_14_5288_fulltext
pascalfrancis_primary_19545497
jstor_primary_2355070
pnas_primary_87_14_5288
pubmedcentral_primary_oai_pubmedcentral_nih_gov_54308
osti_scitechconnect_6151460
proquest_miscellaneous_79878747
proquest_miscellaneous_15830363
crossref_primary_10_1073_pnas_87_14_5288
pubmed_primary_2371271
ProviderPackageCode RNA
PNE
CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1990-07-01
PublicationDateYYYYMMDD 1990-07-01
PublicationDate_xml – month: 07
  year: 1990
  text: 1990-07-01
  day: 01
PublicationDecade 1990
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Proceedings of the National Academy of Sciences - PNAS
PublicationTitleAlternate Proc Natl Acad Sci U S A
PublicationYear 1990
Publisher National Academy of Sciences of the United States of America
National Acad Sciences
Publisher_xml – name: National Academy of Sciences of the United States of America
– name: National Acad Sciences
SSID ssj0009580
Score 1.7432758
Snippet Accelerator mass spectrometry (AMS) is used to determine the amount of carcinogen covalently bound to mouse liver DNA (DNA adduct) following very low-level...
SourceID pubmedcentral
osti
proquest
pubmed
pascalfrancis
crossref
pnas
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5288
SubjectTerms 550201 - Biochemistry- Tracer Techniques
ADDUCTS
AMINES
Analytical biochemistry: general aspects, technics, instrumentation
Analytical, structural and metabolic biochemistry
ANIMALS
BACTERIA
BASIC BIOLOGICAL SCIENCES
Biological and medical sciences
BODY
Body weight
CARBON 14 COMPOUNDS
Carbon Radioisotopes
CARCINOGENS
Carcinogens - metabolism
CHRONIC EXPOSURE
DIGESTIVE SYSTEM
Dioxins - metabolism
DNA
DNA - isolation & purification
DNA - metabolism
DNA ADDUCTS
Dosage
Dose-Response Relationship, Drug
DOSE-RESPONSE RELATIONSHIPS
Fundamental and applied biological sciences. Psychology
GLANDS
Isotopes
Kinetics
LABELLED COMPOUNDS
LIVER
Liver - metabolism
Male
MAMMALS
MAN
MASS SPECTROMETERS
Mass Spectrometry - methods
MASS SPECTROSCOPY
MEASURING INSTRUMENTS
MICE
Mice, Inbred C57BL
MICROORGANISMS
Nucleotides
ORGANIC COMPOUNDS
ORGANS
Phosphorus Radioisotopes
Polychlorinated Dibenzodioxins - metabolism
POLYCYCLIC AROMATIC AMINES
PRIMATES
Quinoxalines - metabolism
Radiocarbon
RODENTS
SENSITIVITY
SPECTROMETERS
SPECTROSCOPY
VERTEBRATES
Title Accelerator Mass Spectrometry in Biomedical Dosimetry: Relationship Between Low-Level Exposure and Covalent Binding of Heterocyclic Amine Carcinogens to DNA
URI https://www.jstor.org/stable/2355070
http://www.pnas.org/content/87/14/5288.abstract
https://www.ncbi.nlm.nih.gov/pubmed/2371271
https://www.proquest.com/docview/15830363
https://www.proquest.com/docview/79878747
https://www.osti.gov/biblio/6151460
https://pubmed.ncbi.nlm.nih.gov/PMC54308
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGENJeEIONlcHwAw9DUUo-nC_eKmCbAFWT2GBvkeM6olKXTE0qBH8L_ykv3NlO6pZVAl6qKHFjR3c_39m--x0hL1Lw2GQoAEgeFy7jnnSLOMUz1yTgqfA5nyi2z3F8dsneX0VXW1u_rKilRVsMxY9b80r-R6pwD-SKWbL_INn-pXADrkG-8AsSht-_kvFICLAa6qDcuQYv2FF5k0hA0M5VPp9OrtcnMXUzVfdxD2DehcDZoVqz-ps7wxgipP2vm-5kQdQwZIwYKKY6A0a5lyCOWnwXSJHNr9FTFViUqKphrIoz4u14ZPu9572dbLqohHG3DTlaJrWYmaZxXOd8vCyR_MH54lws5q2ctXxR9EE_zifnRGJV7H5PwfnonM7kBE847FafaxO5q_c3fLCNfSxsa9OD68H0w7Cn9ADMLNOJ2EOpZ3FwgtyY6Tqk3TRv7LpRZ2ZN2lGgKwv-YU1g-sMSyBVvhmkCNmW43hIkdnOtlCsIEz_QxWRWSb3XjG0fApkmsOrK8YV3yN0AEIPlN06vfIsxOtX5U-b7Ol6qJHy1NqIdcs90v-Jc6fhacDVqMBYY88sbULdS12tBLl94y23rqvXwYMvfunhA7puFEh1prd8lW7J6SHY7ydBjw5f-8hH5acGAIgyoDQM6regSBrSHwWtqg4AaENAeBLQDAQUQ0A4E1ICA1iW1QUAVCKgFAtrWFECwRy5P3l28OXNN0RFXwMqldWUpJZNFzGMvKJg_4b7HvbD00kkRZT6XUZEhpWZYsKjMhC_TOJswuJIeL8rEF-E-2a7qSh4Q6mc8BO9BlGXCWTIpM7W4SmSAmwBhygdk2EkrF4aRHwvDzHIVGZKEOYooX2rKgBz3f7jRZDSbm-4p8fftghCZC70BOUR1yMG_RpJogdF0os1xXcNieHq0oiXLXjJYabEsGZDHqqPuvt0h3fAkL00Y24A875QtByOGJ5O8kvWiyf0oRVc63NwiyVJwLRgMYF8rp_VhSvUHJFrR2v458uevPqmmXxWPfsRCL32y8YsOyc5yPnpKttv5Qj6DFUhbHCmk_gb6_zoT
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Accelerator+mass+spectrometry+in+biomedical+dosimetry%3A+relationship+between+low-level+exposure+and+covalent+binding+of+heterocyclic+amine+carcinogens+to+DNA&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=K+W+Turteltaub&rft.au=J+S+Felton&rft.au=B+L+Gledhill&rft.au=J+S+Vogel&rft.date=1990-07-01&rft.pub=National+Acad+Sciences&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=87&rft.issue=14&rft.spage=5288&rft_id=info:doi/10.1073%2Fpnas.87.14.5288&rft_id=info%3Apmid%2F2371271&rft.externalDBID=n%2Fa&rft.externalDocID=87_14_5288
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F87%2F14.cover.gif
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F87%2F14.cover.gif